Enginzyme Appoints Aymeric de Gantès as New CEO
STOCKHOLM--(BUSINESS WIRE)--May 28, 2025--
Enginzyme AB, a deep-tech company delivering optimized biomanufacturing solutions through cell-free enzyme engineering technology, announced Tuesday that it had appointed Aymeric de Gantès as CEO. Founder Karim Engelmark Cassimjee will develop a new position as Chief Innovation Officer.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250528504132/en/
Aymeric de Gantès
De Gantès comes to enginzyme from Ingredion, a leading multinational food-ingredients company, where he was Global Program Director for Taste Modulation.
'Aymeric is the perfect fit as we position ourselves to accelerate revenue growth,' Cassimjee said. 'He proved that he understands precision technology like enginzyme's from the food-ingredients perspective by building an internal start-up to significant size. We want to apply that knowledge to our business.'
'Enginzyme's team has demonstrated that its technology can deliver what it promises, and without a 'green premium' or resource-heavy up-front investment,' De Gantès said. 'Enzyme-based chemistry is reaching a tipping point in multiple markets. It is the right time to scale-up our technology and provide attractive market solutions.'
Enginzyme has developed clean, streamlined processes with major players in the food oil industry, as well as in fragrances and flavors, personal care and pharmaceuticals.
Chatarina Schneider, Chair of the Board of Directors, said: 'In hiring Aymeric de Gantès, the board aims to convert the strength of enginzyme's science into significant revenue. We are confident he is the right person to take enginzyme into this new stage of development.'
About enginzyme
Enginzyme is enabling the shift to biomanufacturing by unlocking the power of enzymes for more cost-efficient and sustainable production of everyday products. Our patented enzyme immobilization technology enables biomanufacturing without living organisms. It can be deployed using the same tools and techniques used in traditional chemical manufacturing, with lower costs and a much smaller environmental footprint.
Based in Stockholm, enginzyme is a multidisciplinary team of experts in biocatalysis, organic chemistry, enzyme and process engineering, as well as AI and machine learning. This elite team partners with global manufacturers in industries including food, pharma, and personal care to develop complete processes from techno-economic analysis all the way to industrial manufacture, incorporating a high degree of automation for safe, rapid, and reliable development.
www.enginzyme.com
View source version on businesswire.com:https://www.businesswire.com/news/home/20250528504132/en/
CONTACT: Press Contact
James Connell
[email protected]
KEYWORD: SWEDEN EUROPE
INDUSTRY KEYWORD: TECHNOLOGY BIOTECHNOLOGY RETAIL FOOD TECH CHEMICALS/PLASTICS HEALTH MANUFACTURING PHARMACEUTICAL ARTIFICIAL INTELLIGENCE OTHER SCIENCE ENVIRONMENT SUSTAINABILITY SCIENCE FOOD/BEVERAGE
SOURCE: Enginzyme AB
Copyright Business Wire 2025.
PUB: 05/28/2025 09:13 AM/DISC: 05/28/2025 09:12 AM
http://www.businesswire.com/news/home/20250528504132/en
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
2 hours ago
- Bloomberg
Swedish Retail Sales Drop Pressures Riksbank to Cut Again
Swedish retail sales fell the most in more than two decades last month, continuing a run of disappointing data and increasing pressure on the country's central bank to lower rates again. Data from Statistics Sweden showed retail sales declined 4.8% month-on-month compared with April, in the biggest such drop since April 1994.
Yahoo
2 hours ago
- Yahoo
2 Industrials Stocks to Keep an Eye On and 1 to Keep Off Your Radar
Industrials businesses quietly power the physical things we depend on, from cars and homes to e-commerce infrastructure. But they are at the whim of volatile macroeconomic factors that influence capital spending (like interest rates), and the industry has underperformed the market over the past six months as its 2.6% return lagged the S&P 500 by 1.9 percentage points. The elite companies can churn out earnings growth under any circumstance, however, and our mission at StockStory is to help you find them. Keeping that in mind, here are two resilient industrials stocks at the top of our wish list and one that may face trouble. Market Cap: $3.66 billion Founded by a Swedish orphan, Matson (NYSE:MATX) is a provider of ocean transportation and logistics services. Why Is MATX Not Exciting? Customers postponed purchases of its products and services this cycle as its revenue declined by 5.3% annually over the last two years Earnings per share have contracted by 11.6% annually over the last two years, a headwind for returns as stock prices often echo long-term EPS performance Shrinking returns on capital suggest that increasing competition is eating into the company's profitability At $111.98 per share, Matson trades at 11.2x forward P/E. Dive into our free research report to see why there are better opportunities than MATX. Market Cap: $48.92 billion Owning the largest rental fleet in the world, United Rentals (NYSE:URI) provides equipment rental and related services to construction, industrial, and infrastructure industries. Why Could URI Be a Winner? Market share has increased this cycle as its 12.1% annual revenue growth over the last two years was exceptional Highly efficient business model is illustrated by its impressive 25.6% operating margin, and its rise over the last five years was fueled by some leverage on its fixed costs Share repurchases have amplified shareholder returns as its annual earnings per share growth of 16.9% exceeded its revenue gains over the last five years United Rentals's stock price of $752.62 implies a valuation ratio of 16.8x forward P/E. Is now the right time to buy? Find out in our full research report, it's free. Market Cap: $175.1 million Founded by an employee at a real estate rental company, SmartRent (NYSE:SMRT) provides smart home devices and software for multifamily residential properties, single-family rental homes, and student housing communities. Why Are We Positive On SMRT? Offerings are pivotal for their customers' operations as its ARR has averaged 28.5% growth over the past two years Earnings growth has massively outpaced its peers over the last two years as its EPS has compounded at 43% annually SmartRent is trading at $0.93 per share, or 1.2x forward price-to-sales. Is now the time to initiate a position? See for yourself in our full research report, it's free. The market surged in 2024 and reached record highs after Donald Trump's presidential victory in November, but questions about new economic policies are adding much uncertainty for 2025. While the crowd speculates what might happen next, we're homing in on the companies that can succeed regardless of the political or macroeconomic environment. Put yourself in the driver's seat and build a durable portfolio by checking out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025). Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today for free. Find your next big winner with StockStory today. Find your next big winner with StockStory today Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
2 hours ago
- Yahoo
European Penny Stocks To Consider In June 2025
As the pan-European STOXX Europe 600 Index rises, buoyed by easing geopolitical tensions and economic stimulus prospects, the European market presents a landscape of cautious optimism. In this context, penny stocks—despite their old-fashioned moniker—remain an intriguing investment area for those seeking opportunities in smaller or newer companies. By focusing on firms with strong financials and potential growth trajectories, investors can uncover promising opportunities among these often-overlooked stocks. Name Share Price Market Cap Financial Health Rating Orthex Oyj (HLSE:ORTHEX) €4.55 €80.8M ★★★★★★ Maps (BIT:MAPS) €3.50 €46.49M ★★★★★★ Angler Gaming (NGM:ANGL) SEK3.60 SEK269.95M ★★★★★★ Cellularline (BIT:CELL) €2.80 €59.06M ★★★★★☆ Fondia Oyj (HLSE:FONDIA) €4.65 €17.39M ★★★★★★ Abak (WSE:ABK) PLN4.38 PLN11.8M ★★★★★★ Bredband2 i Skandinavien (OM:BRE2) SEK2.475 SEK2.37B ★★★★☆☆ Hifab Group (OM:HIFA B) SEK3.54 SEK215.37M ★★★★★★ Deceuninck (ENXTBR:DECB) €2.125 €293.39M ★★★★★★ Netgem (ENXTPA:ALNTG) €0.994 €33.52M ★★★★★★ Click here to see the full list of 328 stocks from our European Penny Stocks screener. Here's a peek at a few of the choices from the screener. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Banqup Group SA is a fintech company that develops and operates a cloud-based platform for administrative and financial services in Belgium and internationally, with a market cap of €130.33 million. Operations: The company's revenue is derived from two main segments: Digital Services, contributing €46.41 million, and Traditional Communication Services, generating €37.14 million. Market Cap: €130.33M Banqup Group, a fintech company with a market cap of €130.33 million, is currently unprofitable and has seen its losses increase over the past five years. Despite this, it trades significantly below its estimated fair value and maintains a satisfactory net debt to equity ratio of 13.6%. The company's short-term assets exceed both its short-term and long-term liabilities, suggesting financial stability in the near term. However, recent auditor concerns about its ability to continue as a going concern highlight potential risks for investors considering this penny stock in Europe. Take a closer look at Banqup Group's potential here in our financial health report. Assess Banqup Group's future earnings estimates with our detailed growth reports. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Afarak Group SE is involved in the extraction, processing, marketing, and trading of specialised metals across Finland, other EU countries, the United States, China, Africa, and globally with a market cap of €75.02 million. Operations: The company's revenue is primarily derived from its Speciality Alloys segment, which generated €111.28 million, followed by the Ferro Alloys segment with €16.58 million. Market Cap: €75.02M Afarak Group SE, with a market cap of €75.02 million, is navigating challenges typical of penny stocks. Despite being unprofitable, it has successfully reduced its debt to equity ratio from 80.3% to 2% over five years and maintains more cash than total debt, indicating some financial resilience. The company's short-term assets (€57.8M) comfortably cover both its short-term (€17.9M) and long-term liabilities (€31.7M). However, negative operating cash flow raises concerns about debt coverage capabilities. Recent board changes may influence strategic direction as Afarak continues to manage high share price volatility and production fluctuations in its Speciality Alloys segment. Navigate through the intricacies of Afarak Group with our comprehensive balance sheet health report here. Evaluate Afarak Group's historical performance by accessing our past performance report. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Nexam Chemical Holding AB (publ) develops solutions to enhance the properties and performance of plastics in Sweden, Europe, and internationally, with a market cap of SEK324.47 million. Operations: The company generates revenue through its Performance Masterbatch segment, amounting to SEK105.70 million, and Segment Adjustment, contributing SEK89.94 million. Market Cap: SEK324.47M Nexam Chemical Holding AB, with a market cap of SEK324.47 million, is experiencing typical penny stock volatility while showing potential through its innovative solutions in the plastics industry. Despite being unprofitable and reporting a net loss of SEK4.06 million for Q1 2025, Nexam has managed to reduce its debt to equity ratio from 30.4% to 10.8% over five years and maintains short-term assets (SEK76.7M) that exceed both short-term (SEK40.5M) and long-term liabilities (SEK11.4M). Recent commercial production by a key client using Nexam's additives highlights growing traction in the recycling sector, potentially enhancing future revenue streams despite current financial challenges. Click to explore a detailed breakdown of our findings in Nexam Chemical Holding's financial health report. Gain insights into Nexam Chemical Holding's future direction by reviewing our growth report. Unlock more gems! Our European Penny Stocks screener has unearthed 325 more companies for you to here to unveil our expertly curated list of 328 European Penny Stocks. Curious About Other Options? AI is about to change healthcare. These 25 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ENXTBR:BANQ HLSE:AFAGR and OM:NEXAM. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@
